| Serial Number | 88813080 |
| Word Mark | 5 QBD-BIOTECH HUMMINGBIRD ADDED VALUE |
| Filing Date | Thursday, February 27, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 11, 2023 |
| Registration Number | 7102647 |
| Registration Date | Tuesday, July 11, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 8, 2022 |
| Goods and Services | Advice with respect to medical training; advice with respect to training; career coaching services; consultancy with respect to professional training; continuous business training; arranging of professional training courses; industrial training, namely, training in industrialization roadmaps, process development, good manufacturing practices and regulatory compliance; virtual or presential training services in the field of nutrition; arranging and conducting educational congresses, colloquiums, conferences, seminars, and workshops in the field of science and technology, more specifically industrial production, biotechnology and pharmaceutical production, quality system development and implementation, biotechnology, microbiology, biologic therapeutic products, alternative diagnostics and detection methods; Entertainment and educational services in the nature of organizing and conducting competitions in the field of education, research and technology development; educational services, namely, conducting courses of instruction in the field of nutrition; organization of exhibitions for cultural or educational purposes; educational services, namely, conducting seminars, courses of instruction, and educational symposiums in training methodologies; personal trainer services; personnel training in the field of food technologies; publication of journals featuring clinical trial results regarding pharmaceutical preparations; publication of specialized journals in scientific information; training consultancy; training services in the field of medical, microbiological, pharmaceutical, nutritional, and biotechnological research and development, laboratory practices for research and development, and manufacturing |
| Description of Mark | The mark consists of an illustration of a hummingbird with one purple wing, one orange wing, a yellow head, green body, and blue tail. Next to the hummingbird are the words '5 QBD-BIOTECH' in black. Under those words are the words 'HUMMINGBIRD ADDED VALUE' in black. |
| Goods and Services | Animal feed additives for use as nutritional supplements intended for veterinary use; anti diabetic pharmaceuticals; diagnostic kits consisting primarily of monoclonal antibodies for therapies as cancer; chemical preparations for pharmaceutical use, namely, pharmaceutical preparations for the prevention and treatment of cancer, for the treatment of viral and infectious diseases; chemical preparations for the diagnosis of diabetes; chemicopharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of cancer, for the treatment of viral and infectious diseases; dermatological pharmaceutical products; diagnostic radiopharmaceutical preparations; dietetic foods for medical use; dietetic foodstuffs for veterinary use; food for babies; herbal teas for medicinal purposes; intravenous fluid for rehydration, nutrition and the delivery of pharmaceuticals; medicated shampoos; nutritional additives for use as nutritional supplements intended for animal feed for medical use; nutritional supplements for foodstuffs for livestock; nutritional supplements for veterinary use; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of animal diseases, for metabolic disorders and infectious diseases caused by viruses, bacteria, fungi, or parasites, cancer, auto-immune diseases for human diseases; probiotic bacterial formulations for medical use; probiotic bacterial formulations for veterinary use; probiotic preparations for medical use to help maintain a natural balance of the intestinal flora in the digestive system; radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical preparations for cancer and infectious diseases; release agents in the nature of tablet coatings which facilitate the release of nutritional supplements; sanitary preparations for medical use; syringes pre-filled with pharmaceutical preparations for use in chemotherapy for medical use, metabolic disorders and infectious diseases caused by viruses, bacteria, fungi, or parasites, cancer, auto-immune diseases; veterinary products, namely, veterinary pharmaceutical preparations for the prevention of metabolic disorders and infectious diseases caused by viruses, bacteria, fungi, or parasites |
| Pseudo Mark | FIVE QBD-BIOTECH HUMMINGBIRD ADDED VALUE |
| Indication of Colors claimed | The color(s) purple, yellow, orange, green, blue, and black is/are claimed as a feature of the mark. |
| Goods and Services | Advertising services for pharmaceuticals intended for the treatment of diabetes; advertising services with respect to pharmaceuticals; advice in the field of business, namely, in the field of company organization and economics; advice on corporate organization and management; business management and organization consultancy; collection and systematization of information in computer databases; collection of information with respect to market research; commercial business management; compilation and systematization of information in databases; compilation of information for commercial purposes; compilation of scientific information into computer databases; consultancy relating to business management; preparation of business reports and market research; wholesale and retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; business management for freelance service providers |
| Disclaimer with Predetermined Text | "QBD-BIOTECH" AND "ADDED VALUE" |
| Goods and Services | Advisory services in the field of biotechnology, quality control technology, pharmaceutical and biotherapeutic products development, process development; Bacteriological analyses; bacteriological research and analysis; bacteriological research; bacteriological research services; basic and clinical research in the field of respiratory science and medicine; biochemical research and development; biochemical research; biological research services; biological and medical research services; Clinical research in the field of radiology, biotherapeutic products, cancer therapies, viral-based therapies, gene and cell-based therapies; biomedical research services; biotechnological research linked to enzymatic synthesis; biotechnological research linked with the industry; biotechnological research relating to the gasoline industry; biotechnological research; carrying out clinical trials for pharmaceutical products; chemical research; Conducting feasibility studies in the field of bioprocess engineering; bacteriological research and consulting in the field of bacteriological research; consultancy in the field of industrial research; consultancy in the field of pharmaceutical research; consultancy with respect to bacteriology research; consultancy with respect to bacteriology; consultancy with respect to pharmaceutical research and development; design and development of medical diagnostic apparatus; development of pharmaceutical preparations and medicines; development of pharmaceutical products; development services for pharmaceutical products; engineering consultancy in the field of design; engineering consultancy in the field of testings; engineering research; evaluation of the efficacy of pharmaceutical products; scientific research in the field of genetics and its respective therapies; Industrial research in the field of scientific and medical apparatus and machines; information about scientific research in the field of biochemistry and biotechnology; inspection of pharmaceutical products; laboratory analysis in the field of bacteriology; laboratory research in the field of genetic expression; laboratory research services concerning pharmaceutical products; Laboratory research in the field of biotechnology products, recombinant DNA technology, biomass production, protein production, cell and gene therapies, probiotics; pharmaceutical research and development services; preparation of reports concerning industrial design and scientific research and development for scientific research purposes; product research; providing information and data with respect to medical and veterinary research and development; providing information and results relating to scientific research from an online searchable database; providing scientific information in the field of medical disorders and their treatment; provision of information about industrial analysis and research services; provision of information concerning design and development of computer software, networks and systems; provision of information concerning the results of clinical trials for pharmaceutical products; provision of information in the field of medical and scientific research in the field of pharmaceutical products and clinical trials; provision of information relating to technological research; qualitative evaluation of pharmaceutical products; pharmaceutical research and development for the pharmaceutical industry; research and development in the field of antibodies; research and development in the field of biotechnology; research and development in the field of diagnostic preparations; research and development in the field of microorganisms and cells; research and development in the field of pharmaceuticals and biotechnology; research and development of new products for third parties; research and development of new products, on behalf of third parties, in the field of plastics; research and development of new products; research and development of products; research and development of vaccines and medicines; research and development services in the field of antibody technology; research and development services in the field of bacteriology; research and development services in the field of chemistry; research and development services in the field of cytology; research and development services in the field of engineering; research and development services in the field of gene expression systems; research and development services in the field of immunohistology; research and development services in the field of immunology; research and development services with respect to vaccines; research on food products; Industrial research in the field of bioprocesses, unit operations, upstream/downstream processes, aseptic process, contamination control strategy and apparatus; research in the field of food; product research in the field of instrumentation; product research in the field of pharmaceutical products; product research linked to bacteriology; product research relating to design; product research with respect to computer program and software development; product research with respect to medicines; product research with respect to pharmaceuticals; research, development, design and updating of software; Scientific and technological services, namely, scientific analysis in the field of microbiology and biotechnology; scientific and industrial research in the field of microbiology and biotechnology; scientific research and development; scientific research concerning cosmetic products; scientific research for medical purposes; scientific research in the field of chemistry; scientific research in the field of pharmacy; scientific research linked to bacteriology; scientific research services; product development services for conducting early assessments of new pharmaceuticals; scientific research services provided by consultants in the field of scientific research; stem cell research; support services with respect to information technology, namely, monitoring technological functions of computer network systems to ensure data integrity; technical consultancy with respect to product development; technical consulting relating to research services concerning food and dietary supplements; technical consulting relating to technical research in the field of food and beverages; Technical consultation in the field of process development and quality by design regarding biotechnological and pharmaceutical products; technical research in the field of pharmaceutical and biotechnological studies; technological consultancy services in the technology field of industrial production, equipment and bioanalysis; testing on pharmaceutical products |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, March 8, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, March 8, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, March 8, 2020 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, March 8, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOT AVAILABLE |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 01 - Individual |
| Address | Aydat 63970 FR |
| Party Name | NOT AVAILABLE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 01 - Individual |
| Address | Aydat 63970 FR |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Aydat 63970 FR |
| Event Date | Event Description |
| Tuesday, July 11, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, July 11, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Monday, June 5, 2023 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, April 25, 2023 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, April 25, 2023 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Wednesday, April 19, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, April 19, 2023 | TEAS DELETE 1(B) BASIS RECEIVED |
| Wednesday, April 19, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, October 25, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, September 15, 2022 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Wednesday, September 14, 2022 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Friday, September 9, 2022 | ASSIGNED TO PETITION STAFF |
| Monday, August 22, 2022 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Wednesday, March 9, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, March 8, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 8, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 16, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 1, 2022 | ASSIGNED TO LIE |
| Monday, January 31, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 31, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, January 30, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, January 30, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 16, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 16, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, August 16, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, July 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 8, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 8, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, July 5, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, July 3, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, July 3, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Saturday, January 9, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Saturday, January 9, 2021 | FINAL REFUSAL E-MAILED |
| Saturday, January 9, 2021 | FINAL REFUSAL WRITTEN |
| Friday, December 4, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 3, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 3, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 3, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 3, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 3, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, May 18, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, March 10, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, March 8, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 5, 2020 | NEW APPLICATION ENTERED |